Coherus Oncology, Inc.
CHRSNASDAQNASDAQ Global Market·USD·Closed
$2.16
−$0.17 (7.30%)
$2.16
−$0.17 (7.30%)
Not investment advice.Learn more
CHRS has more going for it than against it right now.
Please sign in to view peer comparison data.
Continue with finqOS
SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.
14-day free trial · No credit card required
52W Range
Mid-range
Volume
Market Cap
Small-cap company
P/E Ratio
Cheap relative to earnings
Div Yield
No dividend